Comment on Merck to Lower Prices on Some Drugs, but Not its Blockbusters

Merck to Lower Prices on Some Drugs, but Not its Blockbusters

The drugs singled out for discounts include the flagging hepatitis C treatment Zepatier and six drugs that have lost their patent protection.

 

Comment On This Story